Compare ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund vs DSP Healthcare Fund
Risk
Very High
Very High
Rating
5.0
3.0
Min SIP Amount
₹100
₹100
Expense Ratio
2.09
2.01
NAV
₹46.97
₹49.35
Fund Started
25 Jun 2018
12 Nov 2018
Fund Size
₹6624.58 Cr
₹3514.02 Cr
Exit Load
Exit load of 1% if redeemed within 15 days.
Exit load of 0.50% if redeemed within 1 month.
1 Year
7.27%
10.33%
3 Year
23.93%
20.99%
5 Year
15.49%
14.73%
Equity
96.05%
92.30%
Cash
3.95%
7.70%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 12.20% |
Dr. Reddy's Laboratories Ltd. | 8.22% |
Mankind Pharma Ltd. | 6.98% |
Cipla Ltd. | 6.67% |
Alkem Laboratories Ltd. | 5.67% |
Divi's Laboratories Ltd. | 5.57% |
Cohance Lifesciences Ltd. | 4.31% |
Medplus Health Services Ltd. | 3.66% |
Max Healthcare Institute Ltd. | 3.10% |
Syngene International Ltd. | 2.89% |
Cipla Ltd. | 8.35% |
Ipca Laboratories Ltd. | 8.21% |
Sun Pharmaceutical Industries Ltd. | 8.14% |
Illumina Inc. (USA) | 7.59% |
Sai Life Sciences Ltd. | 6.88% |
Gland Pharma Ltd. | 6.54% |
Globus Medical Inc | 5.72% |
Apollo Hospitals Enterprise Ltd. | 4.81% |
Cohance Lifesciences Ltd. | 4.13% |
Vijaya Diagnostic Centre Ltd. | 3.60% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
The scheme seeks to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
Launch Date
25 Jun 2018
12 Nov 2018
